GKL BIOTEC AG

a subsidiary of the company group Klett-Loch

Based on 25 years of continuous and intensive research on active pharmaceutical ingredients (API’s) in the field of Thymus Peptides, the company GKL-BIOTEC-AG was founded in January 2008. We focus on the development of GKL thymic peptide ingredient complexes for the pharmaceutical and cosmetics industry. In close cooperation with renowned universities we promote the technological transfer of biochemical innovations. The existing results have underlined the success of our approach.

Pharmaceutical Industry

Within the Pharmaceutical Industry our GKL thymic peptide ingredient complexes are suitable for the production of medical products in the sectors of Immunology, Oncology and Dermatology, as well as further therapeutic fields, such as Rheumatic Diseases.

dermatology

In the sector of dermatology our GKL thymic peptide ingredient complexes are suitable for the use in preparations against the different types and causes of hair loss and for the stimulation of new hair growth. Furthermore they are suitable for preparations against skin diseases, such as Lichen Sclerosis and particularly for preparations against the different characteristics linked with the ageing process of the skin.